The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells
- PMID: 18411255
- DOI: 10.1093/hmg/ddn115
The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells
Abstract
A number of studies have associated the S18Y polymorphic variant of UCH-L1 with protection from sporadic Parkinson's Disease (PD). The mechanism involved in this protective function is unknown, but has generally been assumed to be linked to the ubiquitin-proteasome system (UPS). In the current study, we have investigated the effects of overexpression of UCH-L1 and its variants, including S18Y, in neuronal cells. We find that S18Y, but not WT, UCH-L1 confers a specific antioxidant protective function when expressed at physiological levels in human neuroblastoma cells and primary cortical neurons. In contrast, neither WT nor S18Y UCH-L1 appear to directly impact the proteasome, although they both lead to stabilization of free ubiquitin. Lack of WT mouse UCH-L1 in neurons derived from gad mice led to a decrease of free ubiquitin, but no overall decrease in UPS function or enhanced sensitivity to oxidative stress. We conclude that the S18Y variant of UCH-L1 confers a novel antioxidant function that is not present in the WT form and that this function may underlie the protective effects of this variant in certain PD populations. Our results furthermore provide indirect evidence for the importance of oxidative stress as a pathogenetic factor in certain forms of sporadic PD.
Similar articles
-
Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.Hum Mol Genet. 2012 Feb 15;21(4):874-89. doi: 10.1093/hmg/ddr521. Epub 2011 Nov 10. Hum Mol Genet. 2012. PMID: 22076440
-
Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population.Brain Res. 2006 May 4;1087(1):28-32. doi: 10.1016/j.brainres.2006.02.121. Epub 2006 Apr 13. Brain Res. 2006. PMID: 16626667
-
UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.J Neurochem. 2004 Jul;90(2):379-91. doi: 10.1111/j.1471-4159.2004.02485.x. J Neurochem. 2004. PMID: 15228595
-
Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.Curr Protein Pept Sci. 2017;18(7):733-745. doi: 10.2174/1389203717666160217143721. Curr Protein Pept Sci. 2017. PMID: 26899237 Review.
-
The functions of UCH-L1 and its relation to neurodegenerative diseases.Neurochem Int. 2007 Jul-Sep;51(2-4):105-11. doi: 10.1016/j.neuint.2007.05.007. Epub 2007 May 24. Neurochem Int. 2007. PMID: 17586089 Review.
Cited by
-
NGF-Dependent Changes in Ubiquitin Homeostasis Trigger Early Cholinergic Degeneration in Cellular and Animal AD-Model.Front Cell Neurosci. 2018 Dec 13;12:487. doi: 10.3389/fncel.2018.00487. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30618634 Free PMC article.
-
Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease.Mol Neurodegener. 2010 Mar 19;5:11. doi: 10.1186/1750-1326-5-11. Mol Neurodegener. 2010. PMID: 20302621 Free PMC article.
-
Ubiquitin Carboxyl-Terminal Hydrolase L1 and Its Role in Parkinson's Disease.Int J Mol Sci. 2024 Jan 21;25(2):1303. doi: 10.3390/ijms25021303. Int J Mol Sci. 2024. PMID: 38279302 Free PMC article. Review.
-
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disease.Int J Mol Sci. 2020 Nov 10;21(22):8421. doi: 10.3390/ijms21228421. Int J Mol Sci. 2020. PMID: 33182554 Free PMC article. Review.
-
Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction.Biochem J. 2016 Aug 15;473(16):2453-62. doi: 10.1042/BCJ20160082. Biochem J. 2016. PMID: 27515257 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous